1. Home
  2. ELWT vs BOLD Comparison

ELWT vs BOLD Comparison

Compare ELWT & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elauwit Connection Inc.

ELWT

Elauwit Connection Inc.

HOLD

Current Price

$3.05

Market Cap

47.5M

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

N/A

Current Price

$2.40

Market Cap

54.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ELWT
BOLD
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
54.5M
IPO Year
2025
2024

Fundamental Metrics

Financial Performance
Metric
ELWT
BOLD
Price
$3.05
$2.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.2K
★ 86.2K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
18.37
★ 32.47
EPS
★ N/A
N/A
Revenue
★ $21,618,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$111.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 154.48
N/A
52 Week Low
$2.70
$0.96
52 Week High
$9.72
$3.16

Technical Indicators

Market Signals
Indicator
ELWT
BOLD
Relative Strength Index (RSI) 20.92 42.40
Support Level N/A $2.32
Resistance Level $7.99 $2.65
Average True Range (ATR) 0.50 0.10
MACD -0.07 0.01
Stochastic Oscillator 8.53 9.52

Price Performance

Historical Comparison
ELWT
BOLD

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: